142 related articles for article (PubMed ID: 38419562)
1. Elevated INHBA Promotes Tumor Progression of Cervical Cancer.
Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y
Technol Cancer Res Treat; 2024; 23():15330338241234798. PubMed ID: 38419562
[No Abstract] [Full Text] [Related]
2. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
[TBL] [Abstract][Full Text] [Related]
3. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
Liu P; Zhang C; Liao Y; Liu J; Huang J; Xia M; Chen M; Tan H; He W; Xu M; Liu T; Ooi S; Du Q; Qin S; Zhu Y; Zou Q; Wang W; Yao S
Cell Death Dis; 2020 Aug; 11(8):687. PubMed ID: 32826853
[TBL] [Abstract][Full Text] [Related]
4. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.
Pan S; Hu Y; Gan L; Lai J; Zheng P; Zhang Y; Shuai L; Jiang Y; Chen M; Wang J; He Y
Ann Hepatol; 2024; 29(2):101279. PubMed ID: 38123132
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
[TBL] [Abstract][Full Text] [Related]
7. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
8. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway.
Xueqin T; Jinhong M; Yuping H
Bioengineered; 2021 Dec; 12(2):11567-11575. PubMed ID: 34889158
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
10. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
Liu E; Qian X; He Y; Chen K
Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
[TBL] [Abstract][Full Text] [Related]
12. The LIN28B/TGF-β/TGFBI feedback loop promotes cell migration and tumour initiation potential in cholangiocarcinoma.
Puthdee N; Sriswasdi S; Pisitkun T; Ratanasirintrawoot S; Israsena N; Tangkijvanich P
Cancer Gene Ther; 2022 May; 29(5):445-455. PubMed ID: 34548635
[TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.
Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y
Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
15. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
Zhang L; Jiang G; Lu J; Wang L
Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
[TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
[TBL] [Abstract][Full Text] [Related]
17. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
[TBL] [Abstract][Full Text] [Related]
18. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.
Liu Z; Hu C; Zheng L; Liu J; Li K; Li X; Wang Y; Mu W; Chen T; Shi A; Qiu B; Zhang X; Zhang Z; Xu Y
Cell Mol Life Sci; 2022 Aug; 79(9):469. PubMed ID: 35932322
[TBL] [Abstract][Full Text] [Related]
19. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
[TBL] [Abstract][Full Text] [Related]
20. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
